A brain-computer interface (BCI) measures and analyzes brain activity and converts it into computer commands to control external devices. Traditional BCIs usually require full calibration, which is time-consuming and makes BCI systems inconvenient to use. In this study, we propose an online P300 BCI spelling system with zero or shortened calibration based on a convolutional neural network (CNN) and big electroencephalography (EEG) data. Specifically, three methods are proposed to train CNNs for the online detection of P300 potentials: (i) training a subject-independent CNN with data collected from 150 subjects; (ii) adapting the CNN online via a semisupervised learning/self-training method based on unlabeled data collected during the user's online operation; and (iii) fine-tuning the CNN with a transfer learning method based on a small quantity of labeled data collected before the user's online operation. Note that the calibration process is eliminated in the first two methods and dramatically shortened in the third method. Based on these methods, an online P300 spelling system is developed. Twenty subjects participated in our online experiments. Average accuracies of 89.38%, 94.00% and 93.50% were obtained by the subject-independent CNN, the self-training-based CNN and the transfer learning-based CNN, respectively. These results demonstrate the effectiveness of our methods, and thus, the convenience of the online P300-based BCI system is substantially improved.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TNSRE.2023.3259991DOI Listing

Publication Analysis

Top Keywords

data collected
12
method based
12
online
9
brain-computer interface
8
based convolutional
8
convolutional neural
8
neural network
8
big electroencephalography
8
online p300
8
spelling system
8

Similar Publications

Background: Cancer is a leading cause of global mortality, accounting for nearly 10 million deaths in 2020. This is projected to increase by more than 60% by 2040, particularly in low- and middle-income countries. Yet, palliative and psychosocial oncology care is very limited in these countries.

View Article and Find Full Text PDF

Objective: Intraventricular baclofen (IVB) administration is used for the treatment of secondary dystonia associated with cerebral palsy (CP), but it has not been reported as a first-line infusion technique for spasticity. In this study, the authors report outcomes of patients with mixed or isolated spasticity treated with IVB administration.

Methods: A retrospective analysis was performed of consecutive patients treated with IVB between 2019 and 2023.

View Article and Find Full Text PDF

Measurement of CP Violation Observables in D^{+}→K^{-}K^{+}π^{+} Decays.

Phys Rev Lett

December 2024

Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

A search for violation of the charge-parity (CP) symmetry in the D^{+}→K^{-}K^{+}π^{+} decay is presented, with proton-proton collision data corresponding to an integrated luminosity of 5.4  fb^{-1}, collected at a center-of-mass energy of 13 TeV with the LHCb detector. A novel model-independent technique is used to compare the D^{+} and D^{-} phase-space distributions, with instrumental asymmetries subtracted using the D_{s}^{+}→K^{-}K^{+}π^{+} decay as a control channel.

View Article and Find Full Text PDF

Final CONUS Results on Coherent Elastic Neutrino-Nucleus Scattering at the Brokdorf Reactor.

Phys Rev Lett

December 2024

PreussenElektra GmbH, Kernkraftwerk Brokdorf GmbH & Co. oHG, Osterende, 25576 Brokdorf, Germany.

The CONUS experiment studies coherent elastic neutrino-nucleus scattering in four 1 kg germanium spectrometers. Low ionization energy thresholds of 210 eV were achieved. The detectors were operated inside an optimized shield at the Brokdorf nuclear power plant which provided a reactor antineutrino flux of up to 2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!